Official UK procurement notice
Second Variation Agreement to the contract for the provision of goods and services to support the UK Covid-19 Testing Strategy
Authority: Department of Health & Social Care (Central government)
Sectors: Health & Social Care (85) Delivery: UK
Awarded value£114,150,000published contract · exc. VAT
Awarded 7 Jan 2021
Awarded to Uk Biocentre Ltd
Contract term 1 yr 3 moends 14 Jun 2021 · starts 25 Mar 2020
What is being bought
Published requirement descriptionNo description was published on the notice. See the official documents.
CPV: Services provided by medical laboratories
The lotProcurement structure
single lot · no lot value publishedLot #1Labour and equipment to accommodate end point PCR - £1,179,565End point PCR running…
Labour and equipment to accommodate end point PCR - £1,179,565End point PCR running costs - £31.05m
Procedure terms & legal framework
From the official record- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 30 Jun 2021, 17:55 BST
- Last source update
- 30 Jun 2021, 17:55 BST
- FTS notice number
2021/S 000-014990- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02c202Find a Tender
How it was run
Official notice- Submission deadline
- —
Timeline
25 Mar 2020 → 30 Jun 2021 · 2 dates- Contract starts25 Mar 2020
- Notice published30 Jun 2021, 17:55 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecastAwards 1
Awarded value £114,150,0001 contract exc. VAT
Contracts signed 1latest 7 Jan 2021
| Awarded to | Value | Date | Status |
|---|---|---|---|
| Uk Biocentre Ltd | £114,150,000 † | — | Awarded |
Contracts
Contract 014990-2021-C13789-1 · Uk Biocentre Ltd
- Signed
- 7 Jan 2021
- Value
- £114,150,000
- Period
- 24 Aug 2020 – 14 Jun 2021
- Status
- active
- Change Works and additional operational costs to facilitate the use of ultra-high throughput ePCR to support the National Testing Programme.Labour and equipment to accommodate end point PCR - £1,179,565End point PCR running costs - £31.05m, Need for additional works, services or supplies by the original contractor/concessionaire: The modifications were undertaken pursuant to Regulation 72(1)(b) of the Public Contract Regulations 2015. As part of the national testing programme, new high throughput ePCR technology was required in order to meet national demand for testing services. Previous proof of concept activity undertaken by UK Biocentre in its Milton Keynes lab means that it had LGC machines already installed and existing experience of operation of ePCR. Moving the ePCR services to a new facility for a period which is potentially less than a year would cause significant inconvenience and/or substantial duplication of costs for DHSC. The increase in price from the modification does not exceed 50% of the value of the original contract.
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview bodyReview contact point
Bidders & participating suppliers
1 commercial party on the notice- UK Biocentre LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.